Patents by Inventor Shengrong Li

Shengrong Li has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20160166699
    Abstract: The present disclosure provides for a composition which may be used for the solublization of an agent or the oral administration of an agent, the composition comprising, a lyosphosphatidyl compound and at least one of a monoglyceride and a free fatty acid. In certain embodiments, the composition comprises a lyosphosphatidyl compound, a monoglyceride and a free fatty acid. In certain embodiments, the composition comprises an agent, a lyosphosphatidyl compound, a monoglyceride and a free fatty acid.
    Type: Application
    Filed: August 10, 2015
    Publication date: June 16, 2016
    Inventors: Walter A. SHAW, Stephen W. BURGESS, Shengrong LI
  • Publication number: 20160136271
    Abstract: Essentially pure compounds of the formulas (I) to (XX) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources.
    Type: Application
    Filed: January 26, 2016
    Publication date: May 19, 2016
    Inventors: Walter A. SHAW, Stephen W. BURGESS, Shengrong LI, David T. HICKMAN, Maria Pilar LOPEZ-DEBER
  • Publication number: 20160024001
    Abstract: Disclosed are compounds of the general formula I and II (as further defined herein) are useful in the production of inhibitors of sphingolipid synthesis the production of sphingolipids. Suitable sphingolipids, include, but not limited to, sphingosine and compounds incorporating sphingosine or that may use sphingosine as an intermediate or a starting material in their synthesis (including, but not limited to, sphingosine-1-P, ceramide, gangliosides and sphigomyelin). In one contemplated use, compounds of the general formula I and II are useful in the production of sphingosine. In another contemplated use, compounds of the general formula I and II are useful in the production of a sphingofugin. Methods of manufacturing each of the above compounds are also provided.
    Type: Application
    Filed: March 14, 2014
    Publication date: January 28, 2016
    Inventors: Stephen W BURGESS, Walter A. SHAW, Shengrong LI
  • Patent number: 9241988
    Abstract: Essentially pure compounds of the formulas (I) to (XX) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: January 26, 2016
    Assignees: AVANTI POLAR LIPIDS, INC., AC IMMUNE SA
    Inventors: Walter A Shaw, Stephen W Burgess, Shengrong Li, David T Hickman, Maria Pilar Lopez-Deber
  • Publication number: 20150110854
    Abstract: Essentially pure compounds of the formulas (I) to (XXV) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources.
    Type: Application
    Filed: April 12, 2013
    Publication date: April 23, 2015
    Inventors: Walter A Shaw, Stephen W Burgess, Shengrong Li, David T Hickman, Maria Pilar Lopez-Deber
  • Publication number: 20130273149
    Abstract: Essentially pure compounds of the formulas (I) to (XX) are provided. Compositions and methods for enhancing or stimulating an immune response are also provided. The compounds, provided are advantageous in that the compounds are essentially pure and free from contaminants encountered when such compounds are purified from natural sources.
    Type: Application
    Filed: March 15, 2013
    Publication date: October 17, 2013
    Applicants: AC IMMUNE SA, AVANTI POLAR LIPIDS, INC.
    Inventors: Walter A. SHAW, Stephen W. Burgess, Shengrong Li, David T. Hickman, Maria Pilar Lopez-Deber